Vilazodone hydrochloride - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for vilazodone hydrochloride and what is the scope of patent protection?
Vilazodone hydrochloride
is the generic ingredient in two branded drugs marketed by Abbvie, Accord Hlthcare, Alembic, Apotex, Invagen Pharms, and Teva Pharms Usa, and is included in six NDAs. Additional information is available in the individual branded drug profile pages.There are twelve drug master file entries for vilazodone hydrochloride. Fourteen suppliers are listed for this compound.
Summary for vilazodone hydrochloride
| US Patents: | 0 |
| Tradenames: | 2 |
| Applicants: | 6 |
| NDAs: | 6 |
| Drug Master File Entries: | 12 |
| Finished Product Suppliers / Packagers: | 14 |
| Raw Ingredient (Bulk) Api Vendors: | 85 |
| Clinical Trials: | 27 |
| Patent Applications: | 162 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for vilazodone hydrochloride |
| What excipients (inactive ingredients) are in vilazodone hydrochloride? | vilazodone hydrochloride excipients list |
| DailyMed Link: | vilazodone hydrochloride at DailyMed |
Recent Clinical Trials for vilazodone hydrochloride
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| National Alliance on Mental Illness New Mexico | |
| Montana State University | |
| Patient-Centered Outcomes Research Institute |
Medical Subject Heading (MeSH) Categories for vilazodone hydrochloride
Anatomical Therapeutic Chemical (ATC) Classes for vilazodone hydrochloride
Paragraph IV (Patent) Challenges for VILAZODONE HYDROCHLORIDE
| Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
|---|---|---|---|---|---|---|
| VIIBRYD | Tablets | vilazodone hydrochloride | 10 mg, 20 mg, and 40 mg | 022567 | 5 | 2015-01-21 |
US Patents and Regulatory Information for vilazodone hydrochloride
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apotex | VILAZODONE HYDROCHLORIDE | vilazodone hydrochloride | TABLET;ORAL | 208228-001 | Jul 7, 2023 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Alembic | VILAZODONE HYDROCHLORIDE | vilazodone hydrochloride | TABLET;ORAL | 208202-003 | Jan 10, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Accord Hlthcare | VILAZODONE HYDROCHLORIDE | vilazodone hydrochloride | TABLET;ORAL | 208209-003 | Apr 27, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Alembic | VILAZODONE HYDROCHLORIDE | vilazodone hydrochloride | TABLET;ORAL | 208202-002 | Jan 10, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Abbvie | VIIBRYD | vilazodone hydrochloride | TABLET;ORAL | 022567-002 | Jan 21, 2011 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Abbvie | VIIBRYD | vilazodone hydrochloride | TABLET;ORAL | 022567-003 | Jan 21, 2011 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Teva Pharms Usa | VILAZODONE HYDROCHLORIDE | vilazodone hydrochloride | TABLET;ORAL | 208212-001 | Sep 30, 2019 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for vilazodone hydrochloride
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Abbvie | VIIBRYD | vilazodone hydrochloride | TABLET;ORAL | 022567-001 | Jan 21, 2011 | ⤷ Sign Up | ⤷ Sign Up |
| Abbvie | VIIBRYD | vilazodone hydrochloride | TABLET;ORAL | 022567-003 | Jan 21, 2011 | ⤷ Sign Up | ⤷ Sign Up |
| Abbvie | VIIBRYD | vilazodone hydrochloride | TABLET;ORAL | 022567-002 | Jan 21, 2011 | ⤷ Sign Up | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
